ReviewInflammopharmacology2022
Advancement of nanomedicines in chronic inflammatory disorders.
Vikas Jogpal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this paperpooled itcites it
ReviewInflammopharmacology2022
Vikas Jogpal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.